OPKO completes Latin American acquisition

The purchase allows OPKO to expand its Latin American presence, in addition to complementing its business units in Chile and Mexico, and will enable commercialization of the OPKO 4Kscore prostate cancer test in Brazil as a reference laboratory test

Jeffrey Bouley
MIAMI—OPKO Health Inc. has completed its acquisition ofSilcon Comércio, Importacao E Exportacao de Produtos Farmaceuticos e CosmeticosLtda. OPKO announced the acquisition of the San Paulo, Brazil-based company inDecember 2012, though no financial details related to the transaction weredisclosed. The purchase allows OPKO to expand its Latin American presence, inaddition to complementing its business units in Chile and Mexico, and willenable commercialization of the OPKO 4Kscore prostate cancer test in Brazil asa reference laboratory test.
 
 
"We are excited to establish our initial footprint in themost important growth market in South America and initiate commercial effortstowards the introduction of our 4Kscore test in the Brazilian market," Dr.Phillip Frost, chairman and CEO of OPKO, said in a press release.
 
 

Jeffrey Bouley

Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

November 2022 Issue Front Cover

Latest Issue  

• Volume 18 • Issue 11 • November 2022

November 2022

November 2022